Erika Trahan | executive |
John Jacobs | executive |
John Trizzino | executive |
Filip Dubovsky | executive |
James Kelly | executive |
Jiale Song | analyst |
Eric Joseph | analyst |
Brendan Smith | analyst |
Mayank Mamtani | analyst |
Alec Stranahan | analyst |
Vernon Bernardino | analyst |
Ladies and gentlemen, thank you for standing by, and welcome to the Novavax Third Quarter 2023 Financial Results and Operational Highlights Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Erica Schultz.
You may begin.
Good morning, and thank you all for joining us today to discuss our Third Quarter 2023 Operational Highlights and Financial Results. A press release announcing our results is currently available on our website at novavax.com, and an audio archive of this conference call will be available on our website later today. Please turn to Slide 2.